Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Kaul U, Sinha SK, Singh R, Parida AK, Mody R, Abhaichand R, Banker D, Khan A, Kalyansundaram A, Moorthy N, Sharma R, Chandra S, Bordoloi N, Kumar D, Chandra Koduganti S, Gunasekaran S, Kapoor R, Baruah R, Mantri RR, Patil R, Sharma Y, Agrawal DK, Ragava PV, Garg R, Reddy KMK, Chandra P, Kumar S, Arambam P, Khan N, Sudhir K, Bangalore S, TUXEDO- 2 India Investigators

Open source

DOI
10.1016/j.jacc.2026.05.025
Published
2026 Aug 25
Container
Journal of the American College of Cardiology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2026.05.025,
  title = {Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.},
  author = {Kaul U and Sinha SK and Singh R and Parida AK and Mody R and Abhaichand R and Banker D and Khan A and Kalyansundaram A and Moorthy N and Sharma R and Chandra S and Bordoloi N and Kumar D and Chandra Koduganti S and Gunasekaran S and Kapoor R and Baruah R and Mantri RR and Patil R and Sharma Y and Agrawal DK and Ragava PV and Garg R and Reddy KMK and Chandra P and Kumar S and Arambam P and Khan N and Sudhir K and Bangalore S and TUXEDO- 2 India Investigators},
  year = {2026},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2026.05.025},
  url = {https://doi.org/10.1016/j.jacc.2026.05.025}
}

RIS

TY  - JOUR
TI  - Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.
AU  - Kaul U
AU  - Sinha SK
AU  - Singh R
AU  - Parida AK
AU  - Mody R
AU  - Abhaichand R
AU  - Banker D
AU  - Khan A
AU  - Kalyansundaram A
AU  - Moorthy N
AU  - Sharma R
AU  - Chandra S
AU  - Bordoloi N
AU  - Kumar D
AU  - Chandra Koduganti S
AU  - Gunasekaran S
AU  - Kapoor R
AU  - Baruah R
AU  - Mantri RR
AU  - Patil R
AU  - Sharma Y
AU  - Agrawal DK
AU  - Ragava PV
AU  - Garg R
AU  - Reddy KMK
AU  - Chandra P
AU  - Kumar S
AU  - Arambam P
AU  - Khan N
AU  - Sudhir K
AU  - Bangalore S
AU  - TUXEDO- 2 India Investigators
PY  - 2026
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2026.05.025
UR  - https://doi.org/10.1016/j.jacc.2026.05.025
ER  - 

APA

U, K., SK, S., R, S., AK, P., R, M., R, A., D, B., A, K., A, K., N, M., R, S., S, C., N, B., D, K., S, C. K., S, G., R, K., R, B., RR, M., R, P., Y, S., DK, A., PV, R., R, G., KMK, R., P, C., S, K., P, A., N, K., K, S., S, B., & Investigators, T. 2. I. (2026). Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2026.05.025

Source records